Apligraf
-
Extremities
Organogenesis Comparative Effectiveness Research Demonstrating Faster VLU Time to Healing with Apligraf® Showcased at ISPOR
CANTON, Mass. and BALTIMORE, May 31, 2018 /PRNewswire/ — New comparative effectiveness research from Organogenesis Inc. demonstrating faster time to healing and greater healing rates…
Read More » -
Biologics
Apligraf® is First Wound Healing Therapy to Demonstrate Significant Change in Chronic Wound’s Genomic Profile
CANTON, Mass., Jan. 4, 2017 /PRNewswire/ — Apligraf® – an FDA-approved, bioengineered living-cell therapy from Organogenesis Inc. – has become the first wound-healing…
Read More »